US Patent 7569561 2,4-diaminopyrimidines useful for treating cell proliferation diseases
Patent 7569561 was granted and assigned to Boehringer Ingelheim on August, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Anke Baum0
Flavio Solca0
Guido Boehmelt0
Harald Engelhardt0
Heinz Stadtmueller0
Jens Juergen Quant0
Martin Steegmaier0
Stephan Karl Zahn0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+81 characters)
Article
Patent abstract
The present invention encompasses compounds of general formula (1)
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07569561 2,4-diaminopyrimidines useful for treating cell proliferation diseases US Patent 7569561 2,4-diaminopyrimidines useful for treating cell proliferation diseases
Infobox
Patent Number
075695610
Patent Number
75695610
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075695610
Date of Patent
August 4, 2009
0Patent Application Number
116759360
Date Filed
February 16, 2007
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07569561 2,4-diaminopyrimidines useful for treating cell proliferation diseases
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07569561
Date of patent
August 4, 2009
Patent application number
11675936
Date Filed
February 16, 2007
Patent primary examiner
Find more entities like US Patent 7569561 2,4-diaminopyrimidines useful for treating cell proliferation diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
